TKI sensitivity patterns of novel kinase-domain mutations suggest therapeutic opportunities for patients with resistant ALK+ tumors
暂无分享,去创建一个
J. Schatz | V. Gokhale | Mengdie Wang | S. Rajan | A. Amin | Lingxiao Li | M. Groysman | Praechompoo Pongtornpipat | Edgar O. Tapia | A. D. Amin